Fas Ligand Expression in Cancer Cells
Author Information
Author(s): Ryan Aideen E, Lane Sinead, Shanahan Fergus, O'Connell Joe, Houston Aileen M
Primary Institution: National University of Ireland Cork (NUIC)
Hypothesis
The study aimed to comprehensively characterize FasL expression in tumors of both murine and human origin over a 72 hour time period.
Conclusion
The study found that tumor cells can express FasL protein even when FasL mRNA is absent, highlighting the need for complete analysis of FasL expression.
Supporting Evidence
- FasL mRNA expression varied dramatically over time in all cell lines analyzed.
- All cell lines constitutively expressed FasL protein despite variations in mRNA levels.
- The study used multiple methods to confirm FasL expression, including RT-PCR and Western blotting.
Takeaway
Cancer cells can have a protein called FasL that helps them hide from the immune system, even when they don't have the instructions (mRNA) to make it.
Methodology
RNA and protein were extracted from six human and three mouse cancer cell lines, and FasL expression was detected using RT-PCR and Western Blotting.
Potential Biases
Potential bias due to reliance on specific antibodies for detection of FasL.
Limitations
The study focused on a limited number of cell lines and time points, which may not represent all tumor types.
Participant Demographics
The study included six human cancer cell lines and three mouse cancer cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website